HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • 2023 Salary Survey
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • Find Out More
  • Industry Events
    • Webinars
    • Conferences
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
Home » News » Government, Big Pharma, and The People: A Century of Dis-Ease

Government, Big Pharma, and The People: A Century of Dis-Ease

It can be said that society shapes our values toward drugs and drugs shape society. And while drug prices are at the forefront of many voters’ minds, they are not actually the main reason the U.S. spends so much on health care. Even though pharmaceuticals account for a relatively small share of total US healthcare expenditure, the pharmaceutical industry occupies center stage in the debate on reigning in healthcare costs. Because of this, the industry has had, for many years, an outsized claim to fame and controversy, praise and criticisms, and has remained a convenient scapegoat for everything from perpetuating the so-called “sick care” industry to mounting and financing organized opposition to medical marijuana. However, the industry’s true role in the overall health care system is far more complex than most are aware of.

In his latest book ‘Government, Big Pharma, and The People: A Century of Dis-Ease’, Dr. Mickey C. Smith draws upon his 50 years in Big Pharma and academia to fully characterize what is often thought of as the danse macabre between Big Pharma, government, providers, payers, and patients, leaving readers with a complete understanding of the dynamics of the industry and the controversies surrounding it. Smith concludes his well-researched and compelling work with an inside look at how regulations, marketing, and the press affect Big Pharma’s business for better or for worse. Find out more here.

You might be interested in:

  1. Congressional Probe Turns Up Heat on Teva
  2. [Podcast] Telehealth, Standardizing Care, and Drug Prices in Oncology With Dr. Vincent Rajkumar
  3. [Podcast] A Prescription for Fair Drug Pricing
  4. Webinar: Trust: – the Missing Link Impacting Pharma’s Patient Services

 

Advertise With Us!View All JobsPost a JobView Current NewsletterSubscribe to Newsletters
Webinar of the Week
Conference of the Week
Link of the Week

HealthEconomics.Com Jobs Portal

  • Senior Financial Analyst
  • Sr. Manager of HEOR Analytics
  • Manager of Commercial Analytics
  • Senior Director, Evidence Synthesis
  • Biostatistical Analyst
 
Syndicated Reports

Biotech R&D: a target-rich environment

Global Gene Therapy Report 2022-2031

ePrescribing Market – This is How Key Players are Dominating Global Industry

Health Economics and Outcomes Research (HEOR) Services Market to 2028

 
White Papers

Real World Evidence Solutions Global Market Report 2022

AI for Pharma and Biotech Market Pricing Strategy, Industry Latest News, Top Company Analysis, Research Report Analysis and Share by Forecast 2026

Whitepaper – Engaging the End Prescriber: A Practical Guide to Working With Physicians

Adaptive Trial Designs in Early Oncology: Minimizing Risk & Accelerating Timelines

HealthEconomics.Com

HealthEconomics.Com

  • News
  • Conferences
  • Jobs
  • Newsletters
  • White Papers

More Links

  • Jobs
  • Education
  • Graduate Schools

Support & Contact

  • Contact Us

About

  • About Us
  • Advertise
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • 2023 Salary Survey
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • Find Out More
  • Industry Events
    • Webinars
    • Conferences
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists